Back to libraryCosmetic

Melanotan I (Afamelanotide)

Research profile · How we handle evidence

Synthetic alpha-MSH analog that stimulates melanogenesis for tanning and UV protection. FDA-approved for erythropoietic protoporphyria.

Evidence Score

68/100

High confidence

Category

Cosmetic

Therapeutic area

Standard Dose

1-2mg

Daily during loading, then 1-2x weekly

Half-life

~12 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

3

Limited data

Overview

Melanotan I, also known by its pharmaceutical name Afamelanotide, is the more selective cousin of Melanotan II. It stimulates melanin production to give you a natural-looking tan with significantly less sun exposure, but unlike MT-2, it doesn't produce the libido effects or the intense nausea that many people struggle with. It's actually FDA-approved (under the brand name Scenesse) for a rare condition called erythropoietic protoporphyria, where patients are painfully sensitive to light, that's a real approval, not a gray-market claim. The tan it produces builds gradually over 1-2 weeks of daily dosing and then can be maintained with 1-2 injections per week. One important caution: it WILL darken existing moles and freckles, so you need to monitor your skin closely and absolutely avoid it if you have any history of melanoma. For people who want the UV protection and cosmetic tanning without the side-effect rollercoaster of MT-2, this is the smarter choice.

Mechanism of Action

Melanotan I, also known by its pharmaceutical name Afamelanotide, is the more selective cousin of Melanotan II. It stimulates melanin production to give you a natural-looking tan with significantly less sun exposure, but unlike MT-2, it doesn't produce the libido effects or the intense nausea that many people struggle with. It's actually FDA-approved (under the brand name Scenesse) for a rare condition called erythropoietic protoporphyria, where patients are painfully sensitive to light, that's a real approval, not a gray-market claim. The tan it produces builds gradually over 1-2 weeks of daily dosing and then can be maintained with 1-2 injections per week. One important caution: it WILL darken existing moles and freckles, so you need to monitor your skin closely and absolutely avoid it if you have any history of melanoma. For people who want the UV protection and cosmetic tanning without the side-effect rollercoaster of MT-2, this is the smarter choice.

Hair SkinCosmetic

pH & Mixing

10.4

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Natural-looking tan
  • UV protection
  • Reduced sun exposure needed
  • FDA-approved for EPP

Side Effects

  • Nausea
  • Flushing
  • Appetite suppression
  • Darkening of moles

Contraindications

  • Pregnant or breastfeeding women
  • History of melanoma

Structure & Sequence

View 3D structure

Verified structure

Melanotan I (Afamelanotide)

Sequence illustration backed by PubChem match.

Verified via PubChemMatched by name stripped
C78H111N21O191,647 Da13 residues
Source: PubChemLookup: Melanotan IInChIKey UAHFGYDRQSXQEB-LEBBXHLNSA-N
Amino Acid Sequence
Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
Molecular Weight
1,647 Da
Chemical Formula
C78H111N21O19
CAS Number
N/A
Reconstituted pH
10.4
InChIKey
UAHFGYDRQSXQEB-LEBBXHLNSA-N

Stack & Route Context

Stacks with

No entries listed.

Administration

Subcutaneous

Research Status

FDA approved for erythropoietic protoporphyria

Approval Status

Approved

Sports Legal

Permitted

References

No references listed.

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.